NYT > Top StoriesCassava Sciences said that its drug did not significantly reduce cognitive decline in 1,900 people with mild to moderate Alzheimer’s disease. Read More
last news of the week
Trial of Controversial Alzheimer’s Drug Halted After Disappointing Results
NYT > Top StoriesCassava Sciences said that its drug did not significantly reduce cognitive decline in 1,900 people with mild to moderate Alzheimer’s disease. Read More
NYT > Top StoriesCassava Sciences said that its drug did not significantly reduce cognitive decline in 1,900 people with mild to moderate Alzheimer’s disease. Read More